92 cancer biomarkers in 1 µL sample without compromising data quality:Cancer continues to require massive research efforts. It is still a major cause of death but early detection as well as personalized treatment would greatly improve survival rates. Discovering and validating molecular biomarkers will be instrumental in this development. Quantifying large amounts of cancer-related protein biomarkers can reveal novel expression patterns leading to better understanding, diagnosis, and disease monitoring for cancer patients.

The Multiplexed Cancer Immunoassay service screens for 92 putative cancer-related analytes participating in parallel biological mechanisms which may be altered and contribute to disease, e.g. angiogenesis, cell-cell signaling, growth control and inflammation.


Adrenomedullin (ADM) Amphiregulin (AR)
Angiopoietin-1 receptor (TIE2) B-cell activating factor (BAFF)
Betacellulin (BTC) CA242 tumor marker (CA242)
Carbonic Anhydrase IX (CAIX) Carcinoembryonic antigen (CEA)
Caspase-3 (CASP-3) Cathepsin D (CTSD)
C-C motif chemokine 19 (CCL19) C-C motif chemokine 21 (CCL21)
C-C motif chemokine 24 (CCL24) CD40 ligand (CD40-L)
C-X-C motif chemokine 10 (CXCL10) C-X-C motif chemokine 11 (CXCL11)
C-X-C motif chemokine 13 (CXCL13) C-X-C motif chemokine 5 (CXCL5)
C-X-C motif chemokine 9 (CXCL9) Cystatin B (CPI-B)
Early activation antigen CD69 (CD69) Epidermal growth factor (EGF)
Epidermal growth factor receptor (EGFR) Epididymal secretory protein E4 (HE4)
Epiregulin (EPR) Epithelial cell adhesion molecule (Ep-CAM)
Erythropoietin (EPO) E-selectin (CD62E)
Estrogen receptor (ER) Extracellular matrix metalloproteinase inducer (EMMPRIN)
Fas antigen ligand (FasL) Fatty acid binding protein 4 adipocyte (FABP4)
Fms-related tyrosine kinase 3 ligand (Flt3L) Folate receptor alpha (FR-alpha)
Follistatin (FS) Galectin-3 (Gal-3)
Granulocyte-macrophage colony-stimulating factor (GM-CSF) Growth Hormone (GH)
Growth/differentiation factor 15 (GDF-15) Heparin-binding EGF-like growth factor (HB-EGF)
Hepatocyte growth factor (HGF) Hepatocyte growth factor receptor (HGF receptor)
Interferon gamma (IFN-gamma) Interleukin 1 receptor antagonist protein (IL-1ra)
Interleukin 12 (IL-12) Interleukin 17 receptor B (IL17RB)
Interleukin 2 (IL-2) Interleukin 2 receptor subunit alpha (IL2RA)
Interleukin 4 (IL-4) Interleukin 6 (IL-6)
Interleukin 6 receptor subunit alpha (IL6RA) Interleukin 7 (IL-7)
Interleukin 8 (IL-8) Kallikrein-11 (hK11)
Kallikrein-6 (KLK6) Macrophage colony-stimulating factor 1 (CSF-1)
Matrix metalloproteinase-3 (MMP-3) Melanoma-derived growth regulatory protein (MIA)
MHC class I polypeptide-related sequence A (MIC-A) Midkine (MK)
Monocyte chemotactic protein-1 (MCP-1) Myeloid differentiation primary response protein MyD88 (MYD88)
Myeloperoxidase (MPO) Osteoprotegerin (OPG)
Ovarian cancer-related tumor marker 125 (CA-125) Placenta Growth Factor (PlGF)
Platelet endothelial cell adhesion molecule (PECAM-1) Platelet-derived growth factor subunit B (PDGF subunit B)
Prolactin (PRL) Prostasin (PRSS8)
Prostate-specific antigen (PSA) Receptor tyrosine-protein kinase ErbB-2 (ErbB2/Her2)
Receptor tyrosine-protein kinase ErbB-3 (ErbB3/Her3) Receptor tyrosine-protein kinase ErbB-4 (ErbB4/Her4)
Regenerating islet-derived protein 4 (REG-4) Stem cell factor (SCF)
Tartrate-resistant acid phosphatase type 5 (TR-AP) Thrombopoietin (THPO)
Tissue Factor (TF) Transforming growth factor alpha (TGF-alpha)
Latency-associated peptide transforming growth factor beta 1 (LAP TGF-beta-1) Tumor necrosis factor alpha (TNF)
Tumor necrosis factor ligand superfamily member 14 (TNFSF14) Tumor necrosis factor ligand superfamily member 8 (CD30-L)
Tumor necrosis factor receptor 1 (TNF-RI) Tumor necrosis factor receptor 2 (TNF-R2)
Tumor necrosis factor receptor superfamily member 4 (TNFRSF4) Tumor necrosis factor receptor superfamily member 6 (FAS)
Urokinase plasminogen activator surface receptor (U-PAR) Vascular endothelial growth factor A (VEGF-A)
Vascular endothelial growth factor D (VEGF-D) Vascular endothelial growth factor receptor 2 (VEGFR-2)